Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma

Journal of Clinical Investigation

Volumn 122, Issue 4, 2012, Pages 1246-1261

  Howell, Gareth R ^a   Soto, Ileana ^a   Zhu, Xianjun ^a   Ryan, Margaret ^a   Macalinao, Danilo G ^a   Sousa, Gregory L ^a   Caddle, Lura B ^a   MacNicoll, Katharine H ^a   Barbay, Jessica M ^a   Porciatti, Vittorio ^b   Anderson, Michael G ^c   Smith, Richard S ^a   Clark, Abbot F ^d   Libby, Richard T ^e   John, Simon W M ^a,f  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; GLAUCOMA; MONOCYTE; MOUSE; NERVE CELL; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; X RAY;

ANIMALS; AXONS; CELL ADHESION MOLECULES; CRANIAL IRRADIATION; DISEASE MODELS, ANIMAL; ENDOTHELIN-2; GAMMA RAYS; GENE EXPRESSION REGULATION; GLAUCOMA; INTRAOCULAR PRESSURE; L-SELECTIN; MICE; MICE, INBRED DBA; MONOCYTES; NEURITES; OPTIC DISK; RADIATION CHIMERA; RADIOTHERAPY DOSAGE; RETINAL GANGLION CELLS; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; UP-REGULATION; WHOLE-BODY IRRADIATION; X-RAYS;

EID: 84859726329     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI61135     Document Type: Article

References (96)

1. Whitmore AV, Libby RT, John SW. Glaucoma: thinking in new ways-a role for autonomous axonal self-destruction and other compartmentalised processes? Prog Retin Eye Res. 2005;24(6):639-662. (Pubitemid 41254125)
2. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262-267. (Pubitemid 43325451)
3. Quigley HA, Addicks EM. Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage. Arch Ophthalmol. 1981;99(1):137-143. (Pubitemid 11168786)
4. Howell GR, et al. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J Cell Biol. 2007;179(7):1523-1537.
5. May CA, Lütjen-Drecoll E. Morphology of the murine optic nerve. Invest Ophthalmol Vis Sci. 2002; 43(7):2206-2212. (Pubitemid 34700649)
6. Schlamp CL, Li Y, Dietz JA, Janssen KT, Nickells RW. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci. 2006;7:66.
7. Anderson DR. Ultrastructure of human and monkey lamina cribrosa and optic nerve head. Arch Ophthalmol. 1969;82(6):800-814.
8. Anderson DR, Hendrickson AE. Failure of increased intracranial pressure to affect rapid axonal transport at the optic nerve head. Invest Ophthalmol Vis Sci. 1977;16(5):423-426. (Pubitemid 8108643)
9. Chidlow G, Ebneter A, Wood JP, Casson RJ. The optic nerve head is the site of axonal transport disruption, axonal cytoskeleton damage and putative axonal regeneration failure in a rat model of glaucoma. Acta Neuropathol. 2011;121(6):737-751.
10. Morrison JC, Dorman-Pease ME, Dunkelberger GR, Quigley HA. Optic nerve head extracellular matrix in primary optic atrophy and experimental glaucoma. Arch Ophthalmol. 1990;108(7):1020-1024. (Pubitemid 20216027)
11. Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage. Arch Ophthalmol. 1981;99(4):635-649. (Pubitemid 11106037)
12. Quigley HA, Hohman RM, Addicks EM. Quantitative study of optic nerve head capillaries in experimental optic disk pallor. Am J Ophthalmol. 1982; 93(6):689-699. (Pubitemid 12120307)
13. Radius RL, Anderson DR. Morphology of axonal transport abnormalities in primate eyes. Br J Ophthalmol. 1981;65(11):767-777. (Pubitemid 12250473)
14. Jakobs TC, Libby RT, Ben Y, John SW, Masland RH. Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol. 2005;171(2):313-325. (Pubitemid 41540023)
15. May CA, Mittag T. Optic nerve degeneration in the DBA/2NNia mouse: is the lamina cribrosa important in the development of glaucomatous optic neuropathy? Acta Neuropathol. 2006;111(2):158-167.
16. Anderson MG, Libby RT, Gould DB, Smith RS, John SW. High-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma. Proc Natl Acad Sci U S A. 2005; 102(12):4566-4571. (Pubitemid 40397152)
17. Yamada M, Wong FL, Fujiwara S, Akahoshi M, Suzuki G. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat Res. 2004; 161(6):622-632. (Pubitemid 39149570)
18. Otani A, et al. Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage-negative hematopoietic stem cells. J Clin Invest. 2004;114(6):765-774. (Pubitemid 39578735)
19. Crish SD, Sappington RM, Inman DM, Horner PJ, Calkins DJ. Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc Natl Acad Sci U S A. 2010;107(11):5196-5201.
20. Quigley HA, Addicks EM. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest Ophthalmol Vis Sci. 1980; 19(2):137-152. (Pubitemid 10129453)
21. Anderson DR, Hendrickson A. Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Invest Ophthalmol. 1974;13(10):771-783.
22. Porciatti V, Saleh M, Nagaraju M. The pattern electroretinogram as a tool to monitor progressive retinal ganglion cell dysfunction in the DBA/2J mouse model of glaucoma. Invest Ophthalmol Vis Sci. 2007;48(2):745-751. (Pubitemid 351260708)
23. Porciatti V, Chou TH, Feuer WJ. C57BL/6J, DBA/2J, and DBA/2J.Gpnmb mice have different visual signal processing in the inner retina. Mol Vis. 2010;16:2939-2947.
24. Gutman G, Strumban E, Sozontov E, Jenrow K. Xray scalpel - a new device for targeted x-ray brachytherapy and stereotactic radiosurgery. Phys Med Biol. 2007;52(6):1757-1770. (Pubitemid 46646380)
25. Quigley HA, Hohman RM, Addicks EM, Massof RW, Green WR. Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. Am J Ophthalmol. 1983;95(5):673-691. (Pubitemid 13092793)
26. Howell GR, et al. Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma. J Clin Invest. 2011; 121(4):1429-1444.
27. Fevre-Montange M, et al. Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype. Int J Oncol. 2009;35(6):1395-1407.
28. Knosel T, et al. Immunoprofiles of 11 biomarkers using tissue microarrays identify prognostic subgroups in colorectal cancer. Neoplasia. 2005; 7(8):741-747.
29. Kanehisa M, et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res. 2008; 36(database issue):D480-D484.
30. Sherman BT, et al. DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis. BMC Bioinformatics. 2007;8:426.
31. Uchimura K, Rosen SD. Sulfated L-selectin ligands as a therapeutic target in chronic inflammation. Trends Immunol. 2006;27(12):559-565. (Pubitemid 44708834)
32. Lowe JB. Glycosylation in the control of selectin counter-receptor structure and function. Immunol Rev. 2002;186:19-36.
33. Perry VH, Andersson PB, Gordon S. Macrophages and inflammation in the central nervous system. Trends Neurosci. 1993;16(7):268-273. (Pubitemid 23168847)
34. Perry VH, Nicoll JA, Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol. 2010; 6(4):193-201.
35. King IL, Dickendesher TL, Segal BM. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood. 2009;113(14):3190-3197.
36. Fischer HG, Reichmann G. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J Immunol. 2001;166(4):2717-2726. (Pubitemid 32173513)
37. Lehmann U, Heuss ND, McPherson SW, Roehrich H, Gregerson DS. Dendritic cells are early responders to retinal injury. Neurobiol Dis. 2010;40(1):177-184.
38. Mizoguchi A, et al. Dependence of intestinal granuloma formation on unique myeloid DC-like cells. J Clin Invest. 2007;117(3):605-615. (Pubitemid 46348519)
39. Reichmann G, Schroeter M, Jander S, Fischer HG. Dendritic cells and dendritic-like microglia in focal cortical ischemia of the mouse brain. J Neuroimmunol. 2002;129(1-2):125-132. (Pubitemid 34874917)
40. Krishnamoorthy RR, Rao VR, Dauphin R, Prasanna G, Johnson C, Yorio T. Role of the ETB receptor in retinal ganglion cell death in glaucoma. Can J Physiol Pharmacol. 2008;86(6):380-393. (Pubitemid 351821132)
41. Noske W, Hensen J, Wiederholt M. Endothelin-like immunoreactivity in aqueous humor of patients with primary open-angle glaucoma and cataract. Graefes Arch Clin Exp Ophthalmol. 1997;235(9):551-552. (Pubitemid 27445359)
42. Panagis L, Zhao X, Ge Y, Ren L, Mittag TW, Danias J. Gene expression changes in areas of focal loss of retinal ganglion cells (RGC) in the retina of DBA/2J mice. Invest Ophthalmol Vis Sci. 2010;51(4):2024-2034.
43. Tezel G, Kass MA, Kolker AE, Becker B, Wax MB. Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J Glaucoma. 1997; 6(2):83-89. (Pubitemid 27183191)
44. Nakazawa T, et al. Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci. 2006;26(49):12633-12641. (Pubitemid 44904557)
45. Jiang B, et al. Neuroinflammation in advanced canine glaucoma. Mol Vis. 2010;16:2092-2108.
46. Johnson EC, et al. Cell proliferation and interleukin- 6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma. Invest Ophthalmol Vis Sci. 2011; 52(1):504-518.
47. Johnson EC, Jia L, Cepurna WO, Doser TA, Morrison JC. Global changes in optic nerve head gene expression after exposure to elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci. 2007;48(7):3161-3177. (Pubitemid 351261161)
48. Kompass KS, Agapova OA, Li W, Kaufman PL, Rasmussen CA, Hernandez MR. Bioinformatic and statistical analysis of the optic nerve head in a primate model of ocular hypertension. BMC Neurosci. 2008;9:93.
49. Steele MR, Inman DM, Calkins DJ, Horner PJ, Vetter ML. Microarray analysis of retinal gene expression in the DBA/2J model of glaucoma. Invest Ophthalmol Vis Sci. 2006;47(3):977-985. (Pubitemid 46768330)
50. Yang Z, et al. Changes in gene expression in experimental glaucoma and optic nerve transection: the equilibrium between protective and detrimental mechanisms. Invest Ophthalmol Vis Sci. 2007; 48(12):5539-5548. (Pubitemid 351260855)
51. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009;32(12):638-647.
52. Farina C, Aloisi F, Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007;28(3):138-145. (Pubitemid 46283692)
53. Leon S, Yin Y, Nguyen J, Irwin N, Benowitz LI. Lens injury stimulates axon regeneration in the mature rat optic nerve. J Neurosci. 2000;20(12):4615-4626. (Pubitemid 30396627)
54. Yin Y, et al. Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat Neurosci. 2006;9(6):843-852.
55. Wax MB, Tezel G. Immunoregulation of retinal ganglion cell fate in glaucoma. Exp Eye Res. 2009; 88(4):825-830.
56. Schwartz M, London A. Immune maintenance in glaucoma: boosting the body's own neuroprotective potential. J Ocul Biol Dis Infor. 2009;2(2):73-77.
57. Ebneter A, Casson RJ, Wood JP, Chidlow G. Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury. Invest Ophthalmol Vis Sci. 2010;51(12):6448- 6460.
58. Son JL, et al. Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss. Glia. 2010;58(7):780-789.
59. Rosen SD. Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol. 2004; 22:129-156. (Pubitemid 38680420)
60. Wang N, Chintala SK, Fini ME, Schuman JS. Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype. Nat Med. 2001; 7(3):304-309. (Pubitemid 32224345)
61. Krejci J, et al. Epigenetics of multiple myeloma after treatment with cytostatics and gamma radiation. Leuk Res. 2009;33(11):1490-1498.
62. Hwang ST, et al. GlyCAM-1, a physiologic ligand for L-selectin, activates beta 2 integrins on naive peripheral lymphocytes. J Exp Med. 1996; 184(4):1343-1348. (Pubitemid 26354690)
63. Kansas GS. Selectins and their ligands: current concepts and controversies. Blood. 1996; 88(9):3259-3287. (Pubitemid 26365560)
64. Hoke D, et al. Selective modulation of the expression of L-selectin ligands by an immune response. Curr Biol. 1995;5(6):670-678.
65. Johnson EC, Morrison JC. Friend or foe? Resolving the impact of glial responses in glaucoma. J Glaucoma. 2009;18(5):341-353.
66. Flammer J, Mozaffarieh M. What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv Ophthalmol. 2007;52 suppl 2:S162-S173. (Pubitemid 350060968)
67. Downs JC, Roberts MD, Burgoyne CF. Mechanical environment of the optic nerve head in glaucoma. Optom Vis Sci. 2008;85(6):425-435.
68. Zhong L, et al. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest Ophthalmol Vis Sci. 2007;48(3):1212-1218. (Pubitemid 351261416)
69. Lambert WS, Ruiz L, Crish SD, Wheeler LA, Calkins DJ. Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons. Mol Neurodegener. 2011;6(1):4.
70. Almasieh M, Zhou Y, Kelly ME, Casanova C, Di Polo A. Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors. Cell Death Dis. 2010;1:e27.
71. Finger PT. Radiation therapy for orbital tumors: concepts, current use, and ophthalmic radiation side effects. Survey of ophthalmology. 2009;54(5):545-568.
72. Hively W. Is radiation good for you? Or dioxin? Or arsenic? Discover. 2002;12:74-80.
73. Kipnis J, et al. Low-dose gamma-irradiation promotes survival of injured neurons in the central nervous system via homeostasis-driven proliferation of T cells. Eur J Neurosci. 2004;19(5):1191-1198. (Pubitemid 38387196)
74. Sagan LA. On radiation, paradigms, and hormesis. Science. 1989;245(4918):574, 621.
75. Wolff S. Are radiation-induced effects hormetic? Science. 1989;245(4918):575, 621.
76. Otani A, Kojima H, Guo C, Oishi A, Yoshimura N. Low-dose-rate, low-dose irradiation delays neurodegeneration in a model of retinitis pigmentosa. Am J Pathol. 2012;180(1):328-336.
77. Clark AF, Wordinger RJ. The role of steroids in outflow resistance. Exp Eye Res. 2009;88(4):752-759.
78. Marcus MW, et al. Cholesterol-lowering drugs and incident open-angle glaucoma: a population-based cohort study. PLoS One 2012;7(1):e29724.
79. McGwin G Jr, McNeal S, Owsley C, Girkin C, Epstein D, Lee PP. Statins and other cholesterollowering medications and the presence of glaucoma. Arch Ophthalmol. 2004;122(6):822-826. (Pubitemid 38736240)
80. Smith RS, et al. Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant ocular development. Hum Mol Genet. 2000; 9(7):1021-1032. (Pubitemid 30216007)
81. Howell GR, et al. Absence of glaucoma in DBA/2J mice homozygous for wild-type versions of Gpnmb and Tyrp1. BMC Genet. 2007;8:45.
82. Anderson MG, et al. Genetic context determines susceptibility to intraocular pressure elevation in a mouse pigmentary glaucoma. BMC Biol. 2006;4:20.
83. Libby RT, et al. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet. 2005;1(1):17-26.
84. Libby RT, et al. Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neuro-degeneration. Vis Neurosci. 2005;22(5):637-648. (Pubitemid 43237759)
85. Sadun AA, Smith LE, Kenyon KR. Paraphenylenediamine: a new method for tracing human visual pathways. J Neuropathol Exp Neurol. 1983; 42(2):200-206. (Pubitemid 13114130)
86. Anderson MG, et al. Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat Genet. 2002;30(1):81-85.
87. John SW, Hagaman JR, MacTaggart TE, Peng L, Smithes O. Intraocular pressure in inbred mouse strains. Invest Ophthalmol Vis Sci. 1997;38(1):249-253. (Pubitemid 27051543)
88. Savinova OV, et al. Intraocular pressure in genetically distinct mice: an update and strain survey. BMC Genet. 2001;2:12.
89. Porciatti V. The mouse pattern electroretinogram. Doc Ophthalmol. 2007;115(3):145-153. (Pubitemid 350048136)
90. Churchill GA. Using ANOVA to analyze microarray data. Biotechniques. 2004;37(2):173-175.
91. Gautier L, Cope L, Bolstad BM, Irizarry RA. affy - analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20(3):307-315. (Pubitemid 38262761)
92. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100(16):9440-9445. (Pubitemid 37033947)
93. Gene Ontology Consortium. The Gene Ontology (GO) project in 2006. Nucleic Acids Res. 2006; 34(database issue):D322-D326.
94. Li Y, Schlamp CL, Poulsen KP, Nickells RW. Baxdependent and independent pathways of retinal ganglion cell death induced by different damaging stimuli. Exp Eye Res. 2000;71(2):209-213.
95. Lemstra AW, et al. Microglia activation in sepsis: a case-control study. J Neuroinflammation. 2007;4:4.
96. Roux S, Breu V, Ertel SI, Clozel M. Endothelin antagonism with bosentan: a review of potential applications. J Mol Med (Berl). 1999;77(4):364-376. (Pubitemid 29207019)